Compare Stocks: IRTC, PEN, BAX, and SNN

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$23.02 -2.2%	$25.07	$15.73 ▼ $30.00	$12.16B	0.6	4.75 million shs	6.61 million shs
IRTC iRhythm Technologies	$111.75 -0.1%	$118.79	$100.85 ▼ $212.00	$3.69B	1.31	484,600 shs	365,439 shs
PEN Penumbra	$318.86 +0.1%	$321.58	$221.26 ▼ $362.41	$12.54B	0.7	291,392 shs	416,071 shs
SNN Smith & Nephew SNATS	$27.81 +0.0%	$29.75	$27.23 ▼ $37.51	$11.67B	0.55	1.84 million shs	1.17 million shs

10 Best Stocks to Own - Fall 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Fall 2026, despite the economic uncertainty rattling markets right now. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	-0.87%	-3.93%	-9.19%	+18.02%	-1.55%
IRTC iRhythm Technologies	-0.05%	-6.48%	-4.36%	+6.85%	-35.88%
PEN Penumbra	+0.16%	-0.27%	-2.45%	+0.62%	+21.27%
SNN Smith & Nephew SNATS	-0.68%	+0.16%	-6.32%	-7.61%	-25.63%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BAX Baxter International	$23.02 -2.2%	$25.07	$15.73 ▼ $30.00	$12.16B	0.6	4.75 million shs	6.61 million shs
IRTC iRhythm Technologies	$111.75 -0.1%	$118.79	$100.85 ▼ $212.00	$3.69B	1.31	484,600 shs	365,439 shs
PEN Penumbra	$318.86 +0.1%	$321.58	$221.26 ▼ $362.41	$12.54B	0.7	291,392 shs	416,071 shs
SNN Smith & Nephew SNATS	$27.81 +0.0%	$29.75	$27.23 ▼ $37.51	$11.67B	0.55	1.84 million shs	1.17 million shs

10 Best Stocks to Own - Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BAX Baxter International	-0.87%	-3.93%	-9.19%	+18.02%	-1.55%
IRTC iRhythm Technologies	-0.05%	-6.48%	-4.36%	+6.85%	-35.88%
PEN Penumbra	+0.16%	-0.27%	-2.45%	+0.62%	+21.27%
SNN Smith & Nephew SNATS	-0.68%	+0.16%	-6.32%	-7.61%	-25.63%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BAX Baxter International	2.00	Hold	$22.45	-2.46% Downside
IRTC iRhythm Technologies	2.94	Moderate Buy	$179.93	61.01% Upside
PEN Penumbra	2.18	Hold	$367.07	15.12% Upside
SNN Smith & Nephew SNATS	2.00	Hold	$31.91	14.76% Upside

Current Analyst Ratings Breakdown

Latest IRTC, PEN, BAX, and SNN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/14/2026	IRTC iRhythm Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
9/11/2026	SNN Smith & Nephew SNATS	Berenberg Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$33.88
9/8/2026	SNN Smith & Nephew SNATS	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
9/8/2026	SNN Smith & Nephew SNATS	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Neutral
9/4/2026	SNN Smith & Nephew SNATS	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C) ➝ Hold (C+)
9/2/2026	SNN Smith & Nephew SNATS	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Overweight ➝ Equal Weight
8/31/2026	SNN Smith & Nephew SNATS	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral
8/24/2026	PEN Penumbra	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/18/2026	IRTC iRhythm Technologies	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$180.00 ➝ $168.00
8/11/2026	BAX Baxter International	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/10/2026	IRTC iRhythm Technologies	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$160.00 ➝ $168.00

(Data available from 9/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BAX Baxter International	$11.24B	1.06	$5.52 per share	4.17	$11.87 per share	1.94
IRTC iRhythm Technologies	$825.34M	4.46	N/A	N/A	$4.74 per share	23.58
PEN Penumbra	$1.40B	8.95	$4.30 per share	74.07	$36.45 per share	8.75
SNN Smith & Nephew SNATS	$6.16B	1.89	$3.40 per share	8.17	$12.45 per share	2.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BAX Baxter International	-$957M	-$2.07	N/A	11.45	3.58	-9.27%	16.57%	5.24%	10/29/2026 (Estimated)
IRTC iRhythm Technologies	-$44.55M	-$0.43	N/A	77.07	N/A	-1.69%	10.11%	1.53%	10/29/2026 (Estimated)
PEN Penumbra	$177.69M	$4.07	78.34	52.10	2.19	10.67%	10.50%	8.17%	11/4/2026 (Estimated)
SNN Smith & Nephew SNATS	$625M	N/A	N/A	12.04	1.51	N/A	N/A	N/A	N/A

Latest IRTC, PEN, BAX, and SNN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q2 2026	IRTC iRhythm Technologies	-$0.04	$0.58	+$0.62	-$0.01	$219.30 million	$224.17 million
7/30/2026	Q2 2026	BAX Baxter International	$0.3665	$0.56	+$0.1935	$0.24	$2.80 billion	$2.96 billion
7/30/2026	Q2 2026	PEN Penumbra	$1.16	$0.88	-$0.28	$0.88	$389.64 million	$390.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BAX Baxter International	$0.04	0.17%	-11.54%	N/A	N/A
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
PEN Penumbra	N/A	N/A	N/A	N/A	N/A
SNN Smith & Nephew SNATS	$0.93	3.34%	N/A	N/A	N/A

Latest IRTC, PEN, BAX, and SNN Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/4/2026	SNN Smith & Nephew SNATS		$0.3120	2.05%	10/2/2026	10/2/2026	11/6/2026
7/29/2026	BAX Baxter International	quarterly	$0.01	0.15%	8/28/2026	8/28/2026	10/1/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BAX Baxter International	1.39	1.95	1.32
IRTC iRhythm Technologies	3.50	3.86	3.74
PEN Penumbra	0.01	5.75	3.86
SNN Smith & Nephew SNATS	0.62	2.14	1.11

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BAX Baxter International	90.19%
IRTC iRhythm Technologies	N/A
PEN Penumbra	88.88%
SNN Smith & Nephew SNATS	25.64%

Insider Ownership

Company	Insider Ownership
BAX Baxter International	0.17%
IRTC iRhythm Technologies	0.98%
PEN Penumbra	2.90%
SNN Smith & Nephew SNATS	1.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BAX Baxter International	37,500	517.00 million	516.12 million	Optionable
IRTC iRhythm Technologies	2,400	32.96 million	32.64 million	Optionable
PEN Penumbra	4,700	39.39 million	38.25 million	Optionable
SNN Smith & Nephew SNATS	16,988	419.93 million	415.73 million	Optionable

IRTC, PEN, BAX, and SNN Headlines

Recent News About These Companies

Smith & Nephew Plc Announces Result of Cash Tender Offer for 2030 Bonds

September 16 at 5:45 AM | accessnewswire.comA

Smith & Nephew Plc Announces Pricing of Cash Tender Offer for 2030 Bonds

September 15 at 6:00 PM | accessnewswire.comA

Is It Too Late to Buy Smith & Nephew PLC (SNN) After 3.3% Rally? GF Value Says Undervalued

September 14 at 9:00 PM | gurufocus.com

Smith & Nephew SNATS, Inc. $SNN Shares Acquired by Tidal Investments LLC

September 13, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Upgraded to "Buy" at Wall Street Zen

September 13, 2026 | americanbankingnews.com

Wall Street Zen Upgrades Smith & Nephew SNATS (NYSE:SNN) to "Buy"

September 13, 2026 | marketbeat.com

Smith & Nephew Raises $700 Million in 10‑Year U.S. Dollar Notes

September 12, 2026 | theglobeandmail.com

Smith & Nephew SNATS (NYSE:SNN) Stock Rating Upgraded by Zacks Research

September 10, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Hits New 52-Week Low Following Analyst Downgrade

September 9, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Sees Strong Trading Volume - Here's Why

September 8, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Rating Lowered to "Neutral" at Bank of America

September 8, 2026 | marketbeat.com

Smith & Nephew Plc Announces Cash Tender Offer for 2030 Bonds Up To $250m

September 8, 2026 | accessnewswire.comA

Public Employees Retirement System of Ohio Invests $2.17 Million in Smith & Nephew SNATS, Inc. $SNN

September 7, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Downgraded by Wall Street Zen to "Hold"

September 5, 2026 | marketbeat.com

Smith & Nephew keeps Jefferies 'buy' despite H2 growth scepticism

September 4, 2026 | proactiveinvestors.co.uk

Smith & Nephew SNATS (NYSE:SNN) Sets New 52-Week Low on Analyst Downgrade

September 3, 2026 | marketbeat.com

Jupiter Topco LLC Invests $3.15 Million in Smith & Nephew SNATS, Inc. $SNN

September 3, 2026 | marketbeat.com

Panmure Liberum cuts Smith & Nephew target price after disappointing results and CFO exit

September 2, 2026 | proactiveinvestors.co.uk

Smith & Nephew SNATS (NYSE:SNN) Downgraded to "Equal Weight" Rating by Morgan Stanley

September 2, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Shares Gap Up - Should You Buy?

September 1, 2026 | marketbeat.com

Smith & Nephew SNATS (NYSE:SNN) Sees Unusually-High Trading Volume - Time to Buy?

August 31, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IRTC, PEN, BAX, and SNN Company Descriptions

Baxter International NYSE:BAX

$23.02 -0.51 (-2.16%)

Closing price 03:59 PM Eastern

Extended Trading

$22.87 -0.15 (-0.66%)

As of 07:45 PM Eastern

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

iRhythm Technologies NASDAQ:IRTC

$111.75 -0.07 (-0.06%)

Closing price 04:00 PM Eastern

Extended Trading

$111.66 -0.09 (-0.09%)

As of 07:30 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Penumbra NYSE:PEN

$318.86 +0.46 (+0.14%)

Closing price 03:59 PM Eastern

Extended Trading

$318.82 -0.03 (-0.01%)

As of 07:30 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Smith & Nephew SNATS NYSE:SNN

$27.80 +0.01 (+0.02%)

Closing price 03:59 PM Eastern

Extended Trading

$27.78 -0.02 (-0.07%)

As of 07:30 PM Eastern

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IRTC, PEN, BAX, and SNN Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IRTC, PEN, BAX, and SNN Earnings

Compare Dividends

Latest IRTC, PEN, BAX, and SNN Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IRTC, PEN, BAX, and SNN Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IRTC, PEN, BAX, and SNN Company Descriptions

Baxter International NYSE:BAX

iRhythm Technologies NASDAQ:IRTC

Penumbra NYSE:PEN

Smith & Nephew SNATS NYSE:SNN

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools